학술논문

Phase III trial of gemcitabine plus docetaxel versus capecitabine plus docetaxel with planned crossover to the alternate single agent in metastatic breast cancer
Document Type
Article
Source
In Annals of Oncology May 2011 22(5):1094-1101
Subject
Language
ISSN
0923-7534